REGISTERED NUMBER: 06682721 (England and Wales)

Financial Statements for the Year Ended 31 March 2026

for

FACEmed Limited

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

DIRECTORS:

Miss M M Berrange

Mr C G Berrange

N J Baldock

REGISTERED OFFICE:

1 Sopwith Crescent

Shotgate

Wickford

Essex

SS11 8YU

REGISTERED NUMBER:

06682721 (England and Wales)

AUDITORS:

Sygma Chartered Accountants

1 Sopwith Crescent

Wickford

Essex

SS11 8YU

FIXED ASSETS

Tangible assets

4

1,979,775

1,218,185

CURRENT ASSETS

Stocks

71,451

25,000

Debtors

5

82,994

74,234

Cash at bank and in hand

351,736

716,603

506,181

815,837

CREDITORS

Amounts falling due within one year

6

812,112

701,852

NET CURRENT (LIABILITIES)/ASSETS

(305,931

)

113,985

TOTAL ASSETS LESS CURRENT LIABILITIES

1,673,844

1,332,170

PROVISIONS FOR LIABILITIES

403,398

194,913

NET ASSETS

1,270,446

1,137,257

CAPITAL AND RESERVES

Called up share capital

21

21

Retained earnings

7

1,270,425

1,137,236

SHAREHOLDERS' FUNDS

1,270,446

1,137,257

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 31 October 2026 and were signed on its behalf by:

Miss M M Berrange - Director

1.	STATUTORY INFORMATION

FACEmed Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Land and buildings

-

in accordance with the property

Plant and machinery etc

-

15% on reducing balance

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 14 (2025 - 14 ) .

4.	TANGIBLE FIXED ASSETS

Plant and

Land and

machinery

buildings

etc

Totals

£

£

£

COST

At 1 April 2025

345,625

1,304,765

1,650,390

Additions

-

1,066,674

1,066,674

At 31 March 2026

345,625

2,371,439

2,717,064

DEPRECIATION

At 1 April 2025

31,913

400,292

432,205

Charge for year

9,412

295,672

305,084

At 31 March 2026

41,325

695,964

737,289

NET BOOK VALUE

At 31 March 2026

304,300

1,675,475

1,979,775

At 31 March 2025

313,712

904,473

1,218,185

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.26

31.3.25

£

£

Trade debtors

28,292

47,541

Other debtors

54,702

26,693

82,994

74,234

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.26

31.3.25

£

£

Bank loans and overdrafts

443,924

-

Trade creditors

176,429

99,360

Taxation and social security

25,089

122,342

Other creditors

166,670

480,150

812,112

701,852

7.

RESERVES

Retained

earnings

£

At 1 April 2025

1,137,236

Profit for the year

552,689

Dividends

(419,500

)

At 31 March 2026

1,270,425

8.	DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

A Chandler FCA (Senior Statutory Auditor)

for and on behalf of Sygma Chartered Accountants

9.	RELATED PARTY DISCLOSURES

The company is controlled by its director, Ms M Berrange, by virtue of her shareholding. Ms Berrange also controls Face Invest Limited, which holds non-voting A shares in the company.

Face Invest Limited is associated with FaceMed Limited through common ownership and control.

During the year, the company occupied commercial premises owned by Face Invest Limited for which no rent was charged. The arrangement was therefore not conducted on an arm’s length basis.

Dividends totalling £332,000 (2025: £232,000) were paid to Face Invest Limited during the year.